Lexaria Bioscience Corp. – NASDAQ:LEXX
Lexaria Bioscience Corp. stock price today
Lexaria Bioscience Corp. stock price monthly change
Lexaria Bioscience Corp. stock price quarterly change
Lexaria Bioscience Corp. stock price yearly change
Lexaria Bioscience Corp. key metrics
Market Cap | 37.54M |
Enterprise value | N/A |
P/E | -2.22 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 39.97 |
Price/Book | 2.18 |
PEG ratio | -0.02 |
EPS | -0.75 |
Revenue | 318.71K |
EBITDA | -5.70M |
Income | -6.04M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -1626.27% |
Oper. margin | -1785.45% |
Gross margin | 76.07% |
EBIT margin | -1785.45% |
EBITDA margin | -1789.59% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLexaria Bioscience Corp. stock price history
Lexaria Bioscience Corp. stock forecast
Lexaria Bioscience Corp. financial statements
| May 2023 | 93.15K | -2.37M | -2545.9% |
|---|---|---|---|
| Aug 2023 | -3.43K | -1.23M | 36100.17% |
| Feb 2024 | 145K | -649.53K | -447.96% |
| May 2024 | 84K | -1.78M | -2121.06% |
| 2025 | 487.5K | -7.20M | -1478.56% |
|---|---|---|---|
| 2026 | 584.5K | -8.88M | -1520.27% |
| 2027 | 3.51M | -5.75M | -163.57% |
| 2028 | 49.15M | 7.47M | 15.2% |
Analysts Price target
Financials & Ratios estimates
| 2024-11-26 | -0.11 | -0.15 |
|---|
| May 2023 | 5239637 | 1.19M | 22.87% |
|---|---|---|---|
| Aug 2023 | 3083986 | 403.90K | 13.1% |
| Feb 2024 | 6352043 | 204.20K | 3.21% |
| May 2024 | 10018437 | 271.37K | 2.71% |
| May 2023 | -1.78M | -33.64K | 1.71M |
|---|---|---|---|
| Aug 2023 | -1.62M | -68.43K | -121.68K |
| Feb 2024 | -619.61K | -56.99K | 3.45M |
| May 2024 | -1.26M | -22.00K | 5.04M |
Lexaria Bioscience Corp. alternative data
| Aug 2023 | 7 |
|---|---|
| Sep 2023 | 7 |
| Oct 2023 | 7 |
| Nov 2023 | 7 |
| Dec 2023 | 5 |
| Jan 2024 | 5 |
| Feb 2024 | 5 |
| Mar 2024 | 5 |
| Apr 2024 | 5 |
| May 2024 | 5 |
| Jun 2024 | 5 |
| Jul 2024 | 5 |
Lexaria Bioscience Corp. other data
| Period | Buy | Sel |
|---|---|---|
| Jul 2024 | 0 | 2567 |
| Aug 2024 | 1600 | 0 |
| Dec 2024 | 50000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | CHRISTOPHER RICHARD officer: Chief Ex.. | common shares | 27,172 | $2.47 | $67,169 | ||
Purchase | CHRISTOPHER RICHARD officer: Chief Ex.. | common shares | 22,828 | $2.24 | $51,226 | ||
Purchase | TURKEL CATHERINE C. director | common shares | 1,600 | $3.13 | $5,008 | ||
Sale | CARLE VANESSA officer: Secretary | common shares | 2,567 | $4 | $10,268 | ||
Option | CARLE VANESSA officer: Secretary | Stock Options | 2,500 | $1.15 | $2,875 | ||
Option | CARLE VANESSA officer: Secretary | common shares | 2,500 | $1.15 | $2,875 | ||
Purchase | TURKEL CATHERINE C. director | Common Shares | 1,500 | $2.85 | $4,268 | ||
Purchase | DOWNEY GREGORY officer: Chief Financial Officer | common shares | 121 | $2.09 | $253 | ||
Purchase | BUNKA CHRISTOPHER officer: Chief Executive Officer | common shares | 16,600 | $2.1 | $34,860 | ||
Purchase | BUNKA CHRISTOPHER officer: Chief Executive Officer | common shares | 21,900 | $1.99 | $43,537 |
-
What's the price of Lexaria Bioscience Corp. stock today?
One share of Lexaria Bioscience Corp. stock can currently be purchased for approximately $0.85.
-
When is Lexaria Bioscience Corp.'s next earnings date?
Unfortunately, Lexaria Bioscience Corp.'s (LEXX) next earnings date is currently unknown.
-
Does Lexaria Bioscience Corp. pay dividends?
No, Lexaria Bioscience Corp. does not pay dividends.
-
How much money does Lexaria Bioscience Corp. make?
Lexaria Bioscience Corp. has a market capitalization of 37.54M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 105.24% to 464.28K US dollars. Lexaria Bioscience Corp. made a loss 5.8M US dollars in net income (profit) last year or -$0.15 on an earnings per share basis.
-
What is Lexaria Bioscience Corp.'s stock symbol?
Lexaria Bioscience Corp. is traded on the NASDAQ under the ticker symbol "LEXX".
-
What is Lexaria Bioscience Corp.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Lexaria Bioscience Corp.?
Shares of Lexaria Bioscience Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Lexaria Bioscience Corp. have?
As Jul 2024, Lexaria Bioscience Corp. employs 5 workers.
-
When Lexaria Bioscience Corp. went public?
Lexaria Bioscience Corp. is publicly traded company for more then 4 years since IPO on 12 Jan 2021.
-
What is Lexaria Bioscience Corp.'s official website?
The official website for Lexaria Bioscience Corp. is lexariabioscience.com.
-
Where are Lexaria Bioscience Corp.'s headquarters?
Lexaria Bioscience Corp. is headquartered at 100 – 740 McCurdy Road, Kelowna, BC.
-
How can i contact Lexaria Bioscience Corp.?
Lexaria Bioscience Corp.'s mailing address is 100 – 740 McCurdy Road, Kelowna, BC and company can be reached via phone at +250 7656424.
Lexaria Bioscience Corp. company profile:
Lexaria Bioscience Corp.
lexariabioscience.comNASDAQ
5
Biotechnology
Healthcare
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others. DehydraTECH also deliver drugs effectively across the blood brain barrier. It operates a licensed in-house research laboratory and holds intellectual property portfolio with 23 patents granted and approximately 50 patents pending worldwide. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Kelowna, BC V1X 2P7
CIK: 0001348362
ISIN: US52886N4060
CUSIP: 52886N406
